Inflammatory recruitment of leukocytes into the cerebrospinal fluid (CSF) during bacterial meningitis has been shown to contribute significantly to the neurological damage commonly associated with this serious disease. In this study we tested whether or not inhibition of leukocyte rolling, a precondition for firm leukocyte adhesion to vascular endothelium in vivo, may reduce CSF leukocyte recruitment and associated inflammatory changes in rabbits with experimental meningitis. As documented by intravital microscopy of small venules in the rabbit mesentery and tenuissimus muscle, leukocyte rolling was rapidly and profoundly reduced by intravenous treatment with the polysaccharide fucoidin, a homopolymer of sulfated L-fucose known to block the function of the leukocytic "rolling receptor" L-selectin. Moreover, fucoidin treatment dramatically reduced the accumulation of both leukocytes and plasma protein in the CSF of rabbits challenged intrathecally with pneumococcal antigen. These main findings thus illustrate that inhibition of leukocyte rolling, an early and obligatory step in the process of leukocyte extravasation, may be an effective therapeutic approach to attenuate leukocyte-dependent central nervous system damage in bacterial meningitis. (J. Clin. Invest. 1994. 93:929-936.)
Introduction
Bacterial meningitis is characterized by migration of leukocytes and leakage of protein into the subarachnoid space, triggered by local release of inflammatory mediators ( 1) . Apart from being integrated in the host defense, these inflammatory changes, and in particular the accumulation ofleukocytes, contribute significantly to the central nervous system (CNS)' injury commonly associated with bacterial meningitis. In fact, there is evidence to indicate that the phagocytic capacity of leukocytes in the cerebrospinal fluid (CSF) is insufficient (2) (3) (4) , and that the harmful effects of the leukocytes and their 1. Abbreviations used in this paper: MPO, myeloperoxidase; CNS, central nervous system; CSF, cerebrospinal fluid; ZAS, zymosan-activated serum. cytotoxic products outweigh their beneficial role in this disease (4) (5) (6) (7) . Accordingly, a number ofstudies have documented that adjuvant treatment with antiinflammatory agents such as aspirin-like drugs, glucocorticoids, pentoxifylline, and cytokine inhibitors may reduce indices of neurological damage associated with clinical or experimental bacterial meningitis (4, (8) (9) (10) (11) (12) . Recently, Tuomanen et al. (7) demonstrated that inhibition of leukocyte recruitment to the subarachnoid space by selective interference with the process of leukocyte adhesion very effectively reduced meningeal inflammation in an experimental model of pneumococcal meningitis. Thus, intravenous treatment with a monoclonal antibody directed against the common ,B subunit of the leukocytic CD 11/CD 18 complex profoundly inhibited both leukocyte and protein accumulation in the CSF and improved the survival rate of the animals. Using the same treatment strategy, Saez-Llorens et al. (4) obtained similar results in rabbits with experimental Haemophilus influenzae meningitis.
As shown in several intravital microscopic studies of intact microvessels, the leukocyte glycoprotein complex CD 11 / CD 1 8 is ofcritical importance for the process offirm leukocyte adhesion to vascular endothelium of small venules ( 13-16), a step required for the subsequent diapedesis of leukocytes through the vessel wall. Before this stationary adhesion and the subsequent extravasation, the leukocytes roll along the venular endothelial lining at a much lower velocity than free-flowing blood cells ( 13, (17) (18) (19) (20) (21) (22) . This dynamic and reversible type of leukocyte binding to the endothelium, not affected by anti-CD 18 mAbs ( 13, 14) , has recently been shown to be dependent on functional expression of leukocytic L-selectin ( 19, 23, 24) , a carbohydrate-binding adhesion receptor belonging to the selectin family (25) (26) (27) (28) . As first indicated in vitro (29) and directly shown in vivo ( 19, 20, 24) , retardation of circulating leukocytes by reversible binding to the venular endothelium (i.e., rolling) via selectins is necessary to allow firm leukocyte adhesion to develop at physiological blood flow rates. Consequently, there appears to exist a positive correlation between the extent of leukocyte rolling and the magnitude of subsequent evoked firm adhesion (20) . These observations are also in line with previous studies showing that inflammatory leukocyte accumulation in inflamed skin and peritoneum can be markedly reduced by either anti-CD 18 or anti-L-selectin mAbs (13, 14, (30) (31) (32) (33) .
The polysaccharide fucoidin (a homopolymer of sulfated L-fucose) has been found to block leukocyte rolling in a dosedependent manner without interfering with the process of firm leukocyte adhesion per se, and without lowering the circulating leukocyte count or changing the total leukocyte flux (i.e., rolling and free flowing cells) in microvessels in vivo (20, 34 Experimental meningitis model. A previously described meningitis model in female New Zealand White rabbits (3.5-4.5 kg) was used (41) . Briefly, 0.25 ml cerebrospinal fluid was collected from the cisterna magna, whereafter an equal volume of the antigen suspension was injected. Subsequent CSF samples (0.25 ml) were taken after 8 and 24 h. The choice ofthese time points was based on our previous experience with this antigen, i.e., CSF pleocytosis generally peaks during the first 6-9 h after antigen challenge, and after 24 h a substantial number of leukocytes are still present in the CSF (C. Granert, unpublished observation). 10 min before and 8 h after antigen inoculation, l-ml blood samples were drawn from an auricular artery. Fucoidin (10 mg/ kg) or an equivalent volume of PBS was administered intravenously at -5 min, and at 2, 4, and 6 h relative to the intracisternal introduction of antigen. During each cisternal puncture, the animals were anesthetized with 0.25 ml/kg i.m. fluanison/fentanyl (10/0.2 mg/ml; Hypnorm Vet; Janssen Pharmaceutica, Beerse, Belgium) and 0.25 ml/kg i.m. diazepam (Stesolid, 5 mg/ml; Dumex, Copenhagen, Denmark). The experiments were approved by a local ethics committee (applies to all parts of the study described below).
Measurement of circulating leukocyte count and CSF leukocytes, glucose, lactate, andprotein. Total and differential leukocyte counts in blood and CSF were carried out in a Burker chamber after staining. The remaining CSF was centrifuged ( 1,200 g, 10 min), and the supernatants were stored at -70°C until assayed reflectometrically (Kodak 700XRc) for glucose, lactate, and protein using the Kodak Ektachem Clinical Chemistry Slides GLU, LAC, and PROT (Eastman Kodak Company, Rochester, NY).
Intravital microscopic studies ofleukocyte rolling. The microcirculatory behavior of leukocytes was directly observed and quantified in the rabbit tenuissimus muscle using a previously described model for intravital microscopy (42) . Briefly, male New Zealand White rabbits (0.8-1.2 kg) were sedated with diazepam (Stesolid, 5 mg/ml; 0.25 ml/ kg i.m.) and anesthetized with 20% urethane (1.5 g/kg i.m.; Sigma Chemical Co.). Spontaneous breathing was facilitated by tracheal cannulation and body temperature was maintained at 38°C with the aid of a heating pad and an oesophageal thermistor. Carotid artery and jugular vein catheters were inserted for continuous recording of systemic blood pressure, collection of blood samples, and administration of drugs and additional anesthetic. The intact microcirculation in the exposed tenuissimus muscle, continuously superfused (2 ml/min) with a Krebs-Henseleit solution (composition [mM]: KH2PO4, 1.2; NaHCO3, 25.0; NaCl, 118.4; KC1, 4.8; CaCl2, 2.5; and MgSO4, 1.19) at 370C equilibrated with 5% CO2 in N2, was directly observed using an intravital microscope and a salt water immersion lens (SW 25, NA 0.6; E. Leitz, Inc., Rockleigh, NJ). The microscopic image was recorded on videotape by a Panasonic WV-1550 video camera and a Panasonic AG-6010 video recorder. The leukocyte rolling interaction with the microvascular endothelium was determined from video recordings of small venules (inner diameter, 30-40 Aim) in the connective tissue portion of the tenuissimus muscle by counting the number of leukocytes per minute rolling slowly relative to the whole blood flow past a transvascular reference line (rolling leukocyte flux). After a resting period of 10-15 min, after which basal rolling leukocyte flux was found stable, the animals received a single intravenous injection with fucoidin (10 mg/kg) or PBS. At defined points after treatment, the mean rolling leukocyte flux was calculated from two consecutive 1-min recordings. Changes in the rolling leukocyte flux after fucoidin treatment are presented in percent of the rolling flux before treatment. For micrographs of leukocyte rolling (see Fig. 2 ), intravital microscopy of the rabbit mesentery was used because of the high resolution obtainable in this tissue. The mesenteric microvasculature of the rabbit was exposed by a midline abdominal incision (-4 cm) followed by exteriorization of the appendix and terminal ileum. In these experiments, anesthesia, catheters, buffers, etc. were the same as in the studies of the tenuissimus muscle. An automatic microscope camera (Vario Ortomat 2; E. Leitz, Inc.) and Kodak Ectachrome P800/1600 daylight film, exposed at 800 ASA, were used for the micrographs.
Inflammatory skin lesions. Male New Zealand White rabbits ( 1.5-2.1 kg) with their backs shaved 16 h before the experiments were anesthetized with 0.25 ml/kg i.m. fluanison/fentanyl (10/0.2 mg/ml; Hypnorm Vet) and 0.25 ml/kg i.m. diazepam (Stesolid, 5 mg/ml).
Duplicate intradermal injections (100 gl) of PBS and zymosan-activated serum (ZAS) were made at alternate sites in the dorsal region of the animals. Complement activation after a zymosan (Sigma Chemical Co.) concentration in serum of 20 mg/ml, as used in this study, results in -3 ,ug of CSa des Arg/ml serum (43) . The animals were then allowed to recover from the anesthesia and remained in the cages for 4 h at an ambient temperature of 25°C. After this period, the animals were killed with an overdose of anesthesia and the skin lesions were carefully removed and dissected free from fat and muscle tissue and weighed. For determination of leukocyte infiltration into the skin lesions, the skin samples were homogenized in 10 ml 0.5% hexadecyltrimethylammonium bromide and freeze-thawed, whereafter the myeloperoxidase (MPO) activity of the supernatant was determined. The enzyme MPO is abundant in neutrophil leukocytes (44) , and has been found to be a reliable marker for the detection of neutrophil accumulation in inflamed skin areas in vivo (45) . The enzyme activity was determined spectrophotometrically as the change in absorbance at 650 nm (25°C) that occurs in the redox reaction of H202-tetramethylbenzididne catalyzed by MPO. Values are expressed as MPO U/g tissue. Treatment with fucoidin (10 mg/kg i.v.) or an equal volume of PBS was performed 10 min before and 2 h after the intradermal injections.
Statistical analysis. Statistical analysis of paired observations was performed using the Wilcoxon signed ranks test, and independent samples were analyzed by the Wilcoxon-Mann-Whitney test.
Results
Effect offucoidin on leukocyte rolling. Basal rolling leukocyte flux in small venules of the rabbit tenuissimus muscle at the end of the control period was 48±17 /min (mean±SE, n = 5). While intravenous injection of vehicle (PBS) did not affect leukocyte rolling (data not shown), fuco (10 mg/kg) resulted in a rapid -90% dr cyte flux (Fig. I ) . As assessed qualitatively. tively inhibited leukocyte rolling in the mer lation of the rabbit (Fig. 2) . In the tenuissir effect of fucoidin persisted for -2 h, wher( ling gradually increased (Fig. I ) . Parallel that the effect of fucoidin on rolling could reduced arterial blood pressure (Fig. 1 (Fig. 3 ). / treatment with vehicle, intravenous fucoidin 10 min before and 2 h after the intradermal i in a marked reduction of the ZAS-induced (Fig. 3) . Thus, these results strongly suggested that inhibition of leukocyte rolling with fucoidin is indeed an effective method to inhibit leukocyte recruitment into inflamed tissues of the rabbit.
Effect offucoidin on meningeal inflammation. Intrathecal challenge with pneumococcal antigen resulted in pronounced migration of leukocytes into the subarachnoid space of vehicletreated animals (Fig. 4) (Fig. 4) . In control ; associated with animals the mean CSF leukocyte count at 24 h was 1,540 ). Data represent X 106/liter (47% PMNs) (Fig. 4) . No adverse effects on the general condition of the rabbits were observed during or after fucoidin treatment.
In the vehicle-treated group, antigen challenge increased idin administration the mean CSF protein concentration from 0.43 g/liter at 0 h to op in rolling leuko-1.28 g/liter (P < 0.01) and 1.72 g/liter (P < 0.01) at 8 and 24 fucoidin also effech, respectively (Fig. 5 ). In the fucoidin-treated animals, on the senteric microcircuother hand, CSF protein did not increase at 8 h after antigen mus muscle, the full challenge, while a moderate elevation (P < 0.05) occurred after eafter leukocyte rol-24 h (i.e., 18 h after the last fucoidin injection) (Fig. 5 ). recordings showed
In response to antigen challenge, there was a clear-cut innot be attributed to crease (P < 0.01) in the mean CSF lactate concentrations at 8 toreover, as judged and 24 h in both vehicle-and fucoidin-treated animals (Fig. 6 ). d stable throughout However, in the fucoidin-treated group, the mean CSF lactate id not alter the sysconcentration at 8 h was significantly reduced in comparison 5 X 109/liter before with vehicle treatment, i.e., 5.63 vs. 8.31 mmol/liter, respec-109/liter at 30 and tively (Fig. 6 ). At 24 h there was no longer a difference in CSF ins±SE, n = 5). If lactate concentrations between the two groups (Fig. 6 ). cytosis at 1 h after Antigen challenge did not significantly change basal CSF rence was not statisglucose levels in either ofthe two treatment groups as measured at 8 h. Thus, the control glucose levels in the PBS and fucoidin In a recent intravigroups were 4.69±0.18 and 4.75±0.21 mmol/liter, respecwe described that tively, and the corresponding values at 8 h were 4.01±0.62 and increasing doses of 4.64±0.25 mmol/liter (means+SE, n = 8 in both groups). At of subsequent che-24 h, a small but significant (P < 0.05) reduction in CSF gluion (20) . To examcose was seen in both vehicle-and fucoidin-treated animals k, which effectively (3.77±0.41 and 3.36±0.36 mmol/liter, respectively, means±SE, t (see above), may n = 8 in both groups); however, there was no significant differt into an inflamed ence between the two groups. n on local accumuAs described above, fucoidin did not significantly change d as MPO activity) the systemic leukocyte count during the first hour after adminn (ZAS, i.e., actiistration (although a tendency towards leukocytosis was obtinjection of PBS, served '.'t leukocyte and protein accumulation in the CSF ofrabbits challenged intrathecally with pneumococcal antigen. By use of intravital microscopy we could also demonstrate that this polysaccharide very effectively inhibited leukocyte rolling in small venules ofthe rabbit mesentery and tenuissimus muscle. Moreover, fucoidin treatment markedly reduced leukocyte migration into skin lesions, indicating a generalized effect of this carbohydrate on inflammatory leukocyte recruitment.
The reduction in meningeal and skin leukocyte extravasation was evidently a result of interference by fucoidin with leukocyte rolling. This was further supported by the findings that the fucoidin-induced inhibition of leukocyte rolling was not associated with a fall in arterial blood pressure or in the number of circulating leukocytes. Moreover, fucoidin has recently been found not to change the degree of leukocyte flux through the microcirculation (although rolling is inhibited) or to block firm leukocyte adhesion per se (20, 34 ). Yet, the exact molecular mechanism by which fucoidin blocked rolling, and consequently adhesion and extravasation of leukocytes ( 19, 20, 24) , cannot be established from this study. However, based on several lines ofevidence, the observed effects of fucoidin are most likely related to interference with L-selectin function. PBS Figure 4 . CSF leukocytes over time after intrathecal challenge with pneumococcal antigen in rabbits. Fucoidin (10 mg/kg) or an equivalent volume of PBS was administered intravenously at -5 min, and at 2, 4, and 6 h relative to the intracisternal introduction of antigen at time 0 h. Fucoidin, but not PBS, prevented the leukocyte accumulation at 8 h. Note that the effect of fucoidin on leukocyte rolling was relatively short lasting (see Fig. 1 ), suggesting that the moderate pleocytosis at 24 h in fucoidin-treated animals was due to interrupted treatment. Data represent means±SE (n = 8 in both treatment groups). * P < 0.05; ***P < 0.001. (37, 38) . In addition, the maximal inhibitory effect on leukocyte rolling in vivo appears to be similar ( -80-90%) for both anti-L-selectin mAbs and fucoidin ( 19, 20, 23, 24, 34) . While it seems reasonable to suggest that fucoidin inhibits rolling by blocking the function of L-selectin, it is not known whether or not fucoidin also interferes with the in vivo function of the induceable endothelial E-and P-selectins, both of which recognize the same or very similar carbohydrate ligands as Lselectin (27, 28, 46) and promote leukocyte rolling in vitro (29, 47, 48) as well as in vivo (49, 50). If E-and/or P-selectin are involved in the recruitment of leukocytes in the meningitis model, our findings indicate that fucoidin indeed interferes with the function ofthe endothelial selectins. Such an effect by fucoidin could be mediated either via direct blocking of functional E-and/or P-selectin binding domains, or as an indirect consequence of the suggested reciprocal receptor-ligand relationship between leukocytic L-selectin and the endothelial selectins (51, 52). Yet, the purpose ofour study was not to specifically analyze the molecular target actions of fucoidin, but to establish in more general terms the therapeutic potential of inhibiting leukocyte rolling with polysaccharides to attenuate leukocyte-dependent CNS injury associated with bacterial meningitis. In this context, fucoidin is clearly a powerful tool.
The deleterious effect ofleukocyte recruitment into the subarachnoid space was first indicated by Petersdorf and Luttrell (5) , who demonstrated increased survival times in leukopenic dogs with pneumococcal meningitis. More recently, the concept ofleukocyte-mediated CNS damage during meningitis has gained substantial support from two studies demonstrating that specific inhibition of stationary leukocyte adhesion by systemic treatment with anti-CD 18 mAbs markedly reduced meningitic pleocytosis and indices of neurological injury in rabbits (4, 7) . In this study, we have shown that inhibition of leukocyte rolling, a precondition for stationary leukocyte adhesion, is at least as effective as anti-CD 18 therapy with respect to leukocyte recruitment into the CSF. In fact, knowing that firm leukocyte adhesion may also involve leukocytic molecules other than the CD 11 /CD1 8 complex (e.g., fl1 integrins) (25, 53) , treatment with compounds that abolish rolling may prove to be sufficient for preventing leukocyte-dependent tissue injury, and possibly even a more effective strategy than treatment with mAbs interfering with single receptors for stationary leukocyte adhesion. In support of receptors for firm leukocyte adhesion other than CD 1 /CD 18 being involved in meningitic pleocytosis, endotoxin-induced meningitis appears to be less sensitive to treatment with anti-CD 18 mAbs than experimental meningitis induced by live or heat-killed bacteria (4, 7). Moreover, dexamethasone, which may reduce both meningitic cytokine production as well as the expression of several different adhesion receptors mediating leukocyte-endothelium interactions (4, (54) (55) (56) , has been reported to act additiveley with high doses ofanti-CD 18 mAbs in reducing experimental H. influenzae-induced pleocytosis (4).
We found that fucoidin more or less completely inhibited the meningitic increase of both leukocytes and protein in the subarachnoid space, indicating that the blood-brain barrier disturbance was entirely a result ofthe leukocyte extravasation. In the meningitis studies in rabbits by Tuomanen et al. (7) and Sa'ez-Llorens et al. (4) , where anti-CD 18 mAbs and live bacteria were used, protein leakage into the CSF was reduced by -50-60% while pleocytosis was inhibited by -85-90%. Although this may suggest that fucoidin is somewhat more effective than the mAbs with respect to protein leakage, it is important to point out that, in contrast to fucoidin, treatment of uninfected rabbits with anti-CD18 mAb per se may cause a moderate increase in CSF protein levels for unknown reasons (7). Yet, to be able to make a strict comparison, the effect of fucoidin treatment needs to be tested against challenge with live bacteria as well as different antigens. Nevertheless, the lines of evidence discussed above strongly suggest that leakage of protein into the subarachnoid space during meningeal infection is leukocyte dependent to a major extent. Therefore, therapeutic inhibition of leukocyte adhesion and/or rolling in meningitis may be sufficient to effectively reduce the development of vasogenic brain edema. The brain edema caused by leukocytes, alone or in concert with inflammatory mediators, may impair cerebral blood perfusion and tissue oxygenation, potentially resulting in local lactic acidosis ( 1, 57) . In addition, it has been shown in vitro that leukocyte products can directly induce cerebral lactate production in the absence of hypoxia (58) . Further in support of leukocytes contributing to the CSF lactic acidosis seen in meningitis, we found that the peak (at 8 h) increase in CSF lactate after antigen challenge was partially inhibited by fucoidin as compared with vehicle treatment. Yet, it is clear that CSF lactic acidosis in meningitis can develop also independent of leukocytes, as indicated by the significant rise in CSF lactate despite almost total absence of pleocytosis after fucoidin treatment. Moreover, in rabbits with pneumococcal meningitis, Ernst et al. (3) reported no difference in CSF lactate concentrations between normal rabbits and leukopenic animals, and others have found no correlation between CSF lactate and the degree of pleocytosis (6, 41) . In the studies with anti-CD 18 mAb treatment, the results on lactate formation are contradictory, i.e., Sa'ez-Llorens and et al. (4) observed no reduction of CSF lactate levels in rabbits with live H. influenzae-or H. influenzae endotoxin-induced meningitis despite substantial inhibition of pleocytosis (4), while Tuomanen (59), in agreement with our findings, has reported reduced lactate formation after anti-CD 18 treatment of rabbits with pneumococcal meningitis. Apparently, leukocytes may contribute to some extent to meningitic lactate formation; however, additional studies are necessary to clarify the detailed mechanisms of lactate production in bacterial meningitis.
Fucoidin treatment slowly increased the systemic leukocyte count, which is similar to what has previously been observed in rabbits after treatment with anti-CD 18 mAbs (4, 14) . The mechanism behind this increase in circulating leukocytes after fucoidin (or anti-CD 18) treatment is not known. However, given the gradual appearance of the observed leukocytosis (both poly-and mononuclear), one possibility is that inhibition of leukocyte-endothelium interactions prevents the normal elimination of the short-lived PMNs from the circulation, as well as inhibits the homing process of mononuclear cells to peripheral lymphoid tissues. This hypothesis is based on the previous finding that fucoidin may inhibit lymphocyte homing in mice (60) , and the assumption that the normal elimination 934 of PMNs from the circulation involves similar adhesion pathways as when PMNs are recruited to inflamed tissues, i.e., selectin-mediated rolling and CD 11 /CD I8-dependent firm adhesion.
In summary, we have documented that the sulfated polysaccharide fucoidin effectively inhibits leukocyte rolling in the rabbit and, as a consequence, strikingly reduces pleocytosis and increased CSF levels of plasma proteins evoked by intrathecal challenge with pneumococcal antigen. Our findings clearly illustrate the potential of inhibiting leukocyte rolling with certain polysaccharides as a novel and effective therapeutic approach to reduce leukocyte-dependent CNS damage in bacterial meningitis.
